Metraipolis › archive › dc_a50ee711ca27

Germline MC1R Variant Status and Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Melanoma — Europe PMC PMID:40926353

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40926353
DOI
10.1111/pcmr.70050
License (as archived)
solo-consultazione
Archived
2026-11-10T05:12:56.523Z
SHA-256 of the archived text
d193df162fc120862761e3607f67c0cef51d5fb131846952f2bb6a35452898a2
Stable URL of this page
https://metraipolis.com/documento/dc_a50ee711ca27

How to cite

Germline MC1R Variant Status and Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Melanoma — Europe PMC PMID:40926353 — Europe PMC (en), https://europepmc.org/article/MED/40926353 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a50ee711ca27 (Metraipolis archive dc_a50ee711ca27, sha256 d193df162fc120862761e3607f67c0cef51d5fb131846952f2bb6a35452898a2)
BibTeX
@misc{dca50ee711ca27,
  title = {Germline MC1R Variant Status and Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Melanoma — Europe PMC PMID:40926353},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40926353},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a50ee711ca27; sha256 d193df162fc120862761e3607f67c0cef51d5fb131846952f2bb6a35452898a2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40926353. Agents can read the archived copy with the MCP tool read_document.